Stadler R, Nelson S, Warshaw D, Ward G
Elife. 2022; 11.
PMID: 36519527
PMC: 9839348.
DOI: 10.7554/eLife.85171.
Selzer E, Blain D, Hufnagel R, Lupo P, Mitchell L, Brooks B
Surv Ophthalmol. 2022; 67(4):1031-1047.
PMID: 34979194
PMC: 9167256.
DOI: 10.1016/j.survophthal.2021.12.008.
Echevarria-Lucas L, Senciales-Gonzalez J, Medialdea-Hurtado M, Rodrigo-Comino J
Int J Environ Res Public Health. 2021; 18(13).
PMID: 34281132
PMC: 8297364.
DOI: 10.3390/ijerph18137197.
Li K, Feng X, Hikosaka K, Norose K
Invest Ophthalmol Vis Sci. 2021; 62(3):9.
PMID: 33683297
PMC: 7960860.
DOI: 10.1167/iovs.62.3.9.
Patnaik G, Annamalai R, Biswas J
Indian J Ophthalmol. 2020; 68(9):1838-1843.
PMID: 32823400
PMC: 7690489.
DOI: 10.4103/ijo.IJO_1325_20.
Morphological characteristics of ocular toxoplasmosis and its regression pattern on swept-source optical coherence tomography angiography: a case report.
Park J, Lee S, Lee E
BMC Ophthalmol. 2019; 19(1):199.
PMID: 31488090
PMC: 6729000.
DOI: 10.1186/s12886-019-1209-8.
Assessment of ocular toxoplasmosis patients reported at a tertiary center in the northeast of Iran.
Hosseini S, Moghaddas E, Sharifi K, Dadgar Moghaddam M, Shamsian S
Int Ophthalmol. 2018; 38(6):2527-2533.
PMID: 29335806
DOI: 10.1007/s10792-017-0764-3.
Bilateral Chorioretinal Scars in a Child - Case Report.
Tomi A, Stefan I
Maedica (Bucur). 2017; 11(2):163-166.
PMID: 28461838
PMC: 5394571.
Antibiotics versus no treatment for toxoplasma retinochoroiditis.
Pradhan E, Bhandari S, Gilbert R, Stanford M
Cochrane Database Syst Rev. 2016; (5):CD002218.
PMID: 27198629
PMC: 7100541.
DOI: 10.1002/14651858.CD002218.pub2.
Toxoplasmic Retinochoroiditis: Clinical Characteristics and Visual Outcome in a Prospective Study.
Aleixo A, Curi A, Israel Benchimol E, Amendoeira M
PLoS Negl Trop Dis. 2016; 10(5):e0004685.
PMID: 27136081
PMC: 4852945.
DOI: 10.1371/journal.pntd.0004685.
Role of the retinal vascular endothelial cell in ocular disease.
Bharadwaj A, Appukuttan B, Wilmarth P, Pan Y, Stempel A, Chipps T
Prog Retin Eye Res. 2012; 32:102-80.
PMID: 22982179
PMC: 3679193.
DOI: 10.1016/j.preteyeres.2012.08.004.
Why prevent, diagnose and treat congenital toxoplasmosis?.
McLeod R, Kieffer F, Sautter M, Hosten T, Pelloux H
Mem Inst Oswaldo Cruz. 2009; 104(2):320-44.
PMID: 19430661
PMC: 2735102.
DOI: 10.1590/s0074-02762009000200029.
Immunity and Toxoplasma retinochoroiditis.
Wallace G, Stanford M
Clin Exp Immunol. 2008; 153(3):309-15.
PMID: 18549442
PMC: 2527354.
DOI: 10.1111/j.1365-2249.2008.03692.x.
Acquired toxoplasmic retinitis in an immunosuppressed patient: diagnosis by transvitreal fine-needle aspiration biopsy.
Palkovacs E, Correa Z, Augsburger J, Eagle Jr R
Graefes Arch Clin Exp Ophthalmol. 2008; 246(10):1495-7.
PMID: 18500530
DOI: 10.1007/s00417-008-0838-z.
Toxoplasma gondii: from animals to humans.
Tenter A, Heckeroth A, Weiss L
Int J Parasitol. 2000; 30(12-13):1217-58.
PMID: 11113252
PMC: 3109627.
DOI: 10.1016/s0020-7519(00)00124-7.
Is ocular toxoplasmosis caused by prenatal or postnatal infection?.
Gilbert R, Stanford M
Br J Ophthalmol. 2000; 84(2):224-6.
PMID: 10655202
PMC: 1723371.
DOI: 10.1136/bjo.84.2.224.
Human antiretinal antibodies in toxoplasma retinochoroiditis.
Whittle R, Wallace G, Whiston R, Dumonde D, Stanford M
Br J Ophthalmol. 1999; 82(9):1017-21.
PMID: 9893591
PMC: 1722733.
DOI: 10.1136/bjo.82.9.1017.
Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin A.
Dick A, Azim M, Forrester J
Br J Ophthalmol. 1998; 81(12):1107-12.
PMID: 9497474
PMC: 1722078.
DOI: 10.1136/bjo.81.12.1107.
The possible impact of uveitis in blindness: a literature survey.
Suttorp-Schulten M, Rothova A
Br J Ophthalmol. 1996; 80(9):844-8.
PMID: 8962842
PMC: 505625.
DOI: 10.1136/bjo.80.9.844.
Retinal vascular involvement in acute toxoplasmic retinochoroiditis.
Theodossiadis P, Kokolakis S, Ladas I, Kollia A, Chatzoulis D, Theodossiadis G
Int Ophthalmol. 1995; 19(1):19-24.
PMID: 8537191
DOI: 10.1007/BF00156414.